Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 1-3, 2010, Pages

  Travers, Jeffrey B ^a   Kozman, Amal ^a   Mousdicas, Nico ^a   Saha, Chandan ^a   Landis, Megan ^a   Al Hassani, Mohammed ^a   Yao, Weiguo ^a   Yao, Yongxue ^a   Hyatt, Ann Marie ^a   Sheehan, Michael P ^a   Haggstrom, Anita N ^a   Kaplan, Mark H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atopic dermatitis; IL 8; Lipoteichoic acid; Staphylococcus aureus; TNF

Indexed keywords

CEFALEXIN; CEPHALOSPORIN; CLINDAMYCIN; CORTICOSTEROID; CYTOKINE; LIPOTEICHOIC ACID; OXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ECZEMA; EX VIVO STUDY; GENE EXPRESSION; HUMAN; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 73149100108     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.09.052     Document Type: Article

References (34)

1. Abramovits W. Atopic dermatitis. J Am Acad Dermatol 53 suppl 1 (2005) S86-S93
2. Bieber T. Atopic dermatitis. N Engl J Med 358 (2008) 1483-1494
3. Sehra S., Barbé Tuana F.M., Holbreich M., Mousdicas N., Chang C.-H., Travers J.B., et al. Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol 28 (2008) 15-43
4. Leung D.Y. Infection in atopic dermatitis. Curr Opin Pediatr 15 (2003) 399-404
5. Baker B.S. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 144 (2006) 1-9
6. Mandi Y., Endresz V., Krenacs L., Regely K., Degre M., and Beladi I. Tumor necrosis factor production by human granulocytes. Int Arch Allergy Appl Immunol 96 (1991) 102-106
7. Sasaki T., Kano R., Sato H., Nakamura Y., Watanabe S., and Hasegawa A. Effects of staphylococci on cytokine production from human keratinocytes. Br J Dermatol 148 (2003) 46-50
8. Cardona I.D., Cho S.H., and Leung D.Y. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 7 (2006) 273-279
9. Ezepchuk Y.V., Leung D.Y., Middleton M.H., Bina P., Reiser R., and Norris D.A. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol 107 (1996) 603-609
10. Travers J.B., Leung D.Y., Johnson C., Schlievert P., Marques M., Cosgrove J., et al. Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. J Invest Dermatol 120 (2003) 789-794
11. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J., et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS): peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 276 (2001) 25680-25686
12. Lemjabbar H., and Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 8 (2002) 41-46
13. Zhang Q., Mousdicas N., Yi Q., Al-Hassani M., Billings S., Perkins S.M., et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest 115 (2005) 2855-2861
14. Hanifen J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 (1980) 44-47
15. Hanifin J.M., Thurston M., Omoto M., Cherill R., Tofte S.J., and Graeber M. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 10 (2001) 11-18
16. Williamson P., and Kligman A.M. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 45 (1965) 498-503
17. Travers J.B., Edenberg H.J., Zhang Q., Al-Hassani M., Yi Q., Baskaran S., et al. Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol 128 (2008) 455-460
18. Leyden J.J., Marples R.R., and Kligman A.M. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90 (1974) 525-530
19. Williams R.E., Gibson A.G., Aitchison T.C., Lever R., and Mackie R.M. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 123 (1990) 493-501
20. Higaki S., Morohashi M., Yamagishi T., and Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 38 (1999) 265-269
21. Goh C.L., Wong J.S., and Giam Y.C. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol 36 (1997) 653-657
22. Mempel M., Voelcker V., Kollisch G., Plank C., Rad R., Gerhard M., et al. Toll like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not Toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121 (2003) 1389-1396
23. Hattar K., Grandel U., Moeller A., Fink L., Iglhaut J., Hartung T., et al. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation. Crit Care Med 34 (2006) 835-841
24. Chung H.J., Jeon H.S., Sung H., Kim M.N., and Hong S.J. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol 46 (2008) 991-995
25. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
26. Matsui K., Motohashi R., and Nishikawa A. Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res 20 (2000) 321-324
27. Matsui K., and Nishikawa A. Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific immunoglobulin E production in mice. Clin Exp Allergy 33 (2003) 842-848
28. Matsui K., and Nishikawa A. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy 32 (2002) 783-788
29. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12 (2000) 20-26
30. Fournier B., and Philpott D.J. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 18 (2005) 521-540
31. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
32. Mrabet-Dahbi S., Dalpke A.H., Niebuhr M., Frey M., Draing C., Brand S., et al. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 121 (2008) 1013-1019
33. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68 (2000) 6398-6401
34. Ahmad-Nejad P., Mrabet-Dahbi S., Breuer K., Klotz M., Werfel T., Herz U., et al. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113 (2004) 565-567